China Cord Blood EBITDA Margin 2010-2022 | CORBF
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for China Cord Blood (CORBF) over the last 10 years. The current EBITDA margin for China Cord Blood as of March 31, 2022 is .
| China Cord Blood EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-03-31 | $0.20B | $0.10B | 48.22% |
| 2021-12-31 | $0.20B | $0.10B | 48.74% |
| 2021-09-30 | $0.19B | $0.09B | 47.94% |
| 2021-06-30 | $0.19B | $0.09B | 47.06% |
| 2021-03-31 | $0.18B | $0.08B | 46.63% |
| 2020-12-31 | $0.17B | $0.08B | 46.43% |
| 2020-09-30 | $0.17B | $0.08B | 47.37% |
| 2020-06-30 | $0.17B | $0.08B | 46.82% |
| 2020-03-31 | $0.17B | $0.08B | 45.09% |
| 2019-12-31 | $0.17B | $0.07B | 42.11% |
| 2019-09-30 | $0.16B | $0.06B | 39.38% |
| 2019-06-30 | $0.15B | $0.06B | 38.16% |
| 2019-03-31 | $0.15B | $0.06B | 38.10% |
| 2018-12-31 | $0.15B | $0.05B | 33.77% |
| 2018-09-30 | $0.15B | $0.05B | 32.89% |
| 2018-06-30 | $0.15B | $0.05B | 30.46% |
| 2018-03-31 | $0.15B | $0.04B | 29.53% |
| 2017-12-31 | $0.13B | $0.04B | 32.09% |
| 2017-09-30 | $0.13B | $0.05B | 36.80% |
| 2017-06-30 | $0.12B | $0.04B | 36.44% |
| 2017-03-31 | $0.11B | $0.04B | 35.14% |
| 2016-12-31 | $0.11B | $0.04B | 34.91% |
| 2016-09-30 | $0.10B | $0.03B | 29.13% |
| 2016-06-30 | $0.10B | $0.03B | 29.41% |
| 2016-03-31 | $0.10B | $0.03B | 29.13% |
| 2015-06-30 | $0.05B | $0.02B | 32.69% |
| 2014-09-30 | $0.10B | $0.04B | 40.82% |
| 2014-06-30 | $0.10B | $0.04B | 41.67% |
| 2014-03-31 | $0.09B | $0.04B | 40.22% |
| 2013-12-31 | $0.09B | $0.04B | 38.46% |
| 2013-09-30 | $0.09B | $0.04B | 38.89% |
| 2013-06-30 | $0.09B | $0.03B | 37.93% |
| 2013-03-31 | $0.08B | $0.03B | 39.29% |
| 2012-12-31 | $0.08B | $0.03B | 39.74% |
| 2012-09-30 | $0.07B | $0.03B | 36.23% |
| 2012-06-30 | $0.06B | $0.02B | 37.50% |
| 2012-03-31 | $0.06B | $0.02B | 36.67% |
| 2011-12-31 | $0.06B | $0.02B | 37.29% |
| 2011-09-30 | $0.06B | $0.02B | 37.93% |
| 2011-06-30 | $0.06B | $0.02B | 36.36% |
| 2011-03-31 | $0.05B | $0.02B | 34.62% |
| 2010-12-31 | $0.05B | $0.02B | 45.65% |
| 2010-09-30 | $0.04B | $0.02B | 47.62% |
| 2010-06-30 | $0.04B | $0.02B | 51.28% |
| 2010-03-31 | $0.04B | $0.03B | 70.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $132.070B | 24.77 |
| Elevance Health (ELV) | United States | $84.109B | 10.85 |
| CVS Health (CVS) | United States | $76.951B | 9.56 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $22.591B | 34.29 |
| Natera (NTRA) | United States | $20.935B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.529B | 0.00 |
| Solventum (SOLV) | United States | $12.251B | 12.97 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Revvity (RVTY) | United States | $10.529B | 18.12 |
| ICON (ICLR) | Ireland | $10.336B | 9.61 |
| Viatris (VTRS) | United States | $9.730B | 3.34 |
| Doximity (DOCS) | United States | $9.525B | 44.37 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| HealthEquity (HQY) | United States | $8.564B | 42.13 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.176B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.716B | 13.16 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.048B | 37.47 |
| Bausch + Lomb (BLCO) | Canada | $3.990B | 23.52 |
| Sotera Health (SHC) | United States | $3.452B | 19.61 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Alignment Healthcare (ALHC) | United States | $2.865B | 0.00 |
| Concentras Parent (CON) | United States | $2.710B | 15.66 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.091B | 8.91 |
| GeneDx Holdings (WGS) | United States | $2.043B | 78.68 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.759B | 38.72 |
| PACS (PACS) | United States | $1.497B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.336B | 26.71 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.944B | 14.74 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| Nutex Health (NUTX) | United States | $0.890B | 13.45 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 7.44 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.626B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Enhabit (EHAB) | United States | $0.518B | 42.58 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 11.08 |
| SBC Medicals (SBC) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Oncology Institute (TOI) | United States | $0.228B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.215B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.066B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |